首頁 > 市場調查報告書 > 醫療設備

體外診斷

大便潛血試驗市場規模、佔有率及成長分析（依檢測類型、最終用戶及地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1902484

大便潛血試驗市場規模、佔有率及成長分析（依檢測類型、最終用戶及地區分類）－2026-2033年產業預測

Fecal Occult Testing Market Size, Share, and Growth Analysis, By Test type (Immuno-FOB ELISA Test, Lateral Flow Immuno-FOB Test), By End-User (Hospitals and Clinics), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月18日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球大便潛血試驗市場規模預計在 2024 年達到 2068.2 億美元，從 2025 年的 2221.2 億美元成長到 2033 年的 3932.2 億美元，在預測期（2026-2033 年）內複合年成長率為 7.4%。

全球大便潛血試驗市場對於檢測糞便中的隱血至關重要，而糞便隱血可能預示著多種疾病，包括大腸直腸癌、息肉和發炎性腸道疾病。大腸直腸癌發生率的上升、政府的宣傳活動以及醫療和實驗室技術的進步，都在推動這種篩檢方法的需求。儘管存在公眾認知度低和費用方面的顧慮等障礙，但面向消費者的直接檢測服務的興起和在線檢測設備的普及帶來了許多機會。該市場涵蓋多種產品類型，例如癒創木脂大便潛血試驗和免疫學大便潛血試驗，並應用於包括醫院和診斷檢查室在內的各種臨床場所。此外，該市場在全球主要地區也廣泛分佈。

推動全球大便潛血試驗市場發展的因素

全球大便潛血試驗市場受到大眾對大腸直腸癌及其定期篩檢重要性認知不斷提高的顯著影響。諸如健康政策和宣傳宣傳活動等措施鼓勵個人和醫療專業人員將篩檢放在首位。此外，政府主導的計畫和已製定的指南，推廣針對特定年齡層的定期大便潛血試驗，也促進了此類診斷檢測需求的成長。教育和系統性建議的結合，鼓勵人們採取更積極主動的方式來預防和檢測結直腸癌，從而推動大便潛血試驗作為一項重要的健康措施在市場中佔據一席之地。

限制全球大便潛血試驗市場的因素

全球大便潛血試驗市場面臨假陽性和假陰性結果帶來的重大挑戰，這些結果會削弱診斷的可靠性，並加劇患者的焦慮和過度自信。假陽性結果可能導致不必要的額外檢查或侵入性操作，而假陰性結果會延誤診斷，進而延遲必要的治療。因此，解決大便潛血試驗在靈敏度和特異性方面的局限性，以確保人們對其診斷能力的持續信心至關重要。透過提高這些檢測的準確性，市場可以更好地服務醫療服務提供者和患者，最終改善治療效果和醫療品質。

全球大便潛血試驗市場趨勢

全球大便潛血試驗市場正朝著就地檢驗（POC檢測）方向發展，這主要受對更快檢測結果和更高便利性的需求所驅動。這一趨勢凸顯了基層醫療機構、社區健康診所和檢測設施有限的偏遠地區檢測的可及性。開發易於使用、經濟高效的照護現場大便潛血試驗，為擴大篩檢和診斷服務提供了重要機遇，尤其是在資源匱乏的地區。隨著醫療系統將早期發現和預防措施置於優先地位，市場蓄勢待發，可望迎來成長，並推動創新，從而提高不同人群的檢測可及性，改善患者預後。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Quidel Corporation（United States）
Wondfo（China）
Siemens Healthineers（Germany）
Eiken Chemical Co., Ltd.（Japan）
Biohit Oyj（Finland）
Becton, Dickinson and Company（BD）（United States）
Trinity Biotech（Ireland）
Meridian Bioscience（United States）
Beckman Coulter（United States）
Inova Diagnostics（United States）
Bio-Rad Laboratories（United States）
Abbott Laboratories（United States）
Roche Diagnostics（Switzerland）
Sysmex Corporation（Japan）
US Diagnostics（United States）
Sekisui Diagnostics（United States）
FUJIFILM Wako Pure Chemical Corporation（Japan）
Helena Laboratories（United States）
Exact Sciences Corp.（United States）

結論與建議

簡介目錄

Product Code: SQMIG35A2892

Global Fecal Occult Testing Market size was valued at USD 206.82 Billion in 2024 and is poised to grow from USD 222.12 Billion in 2025 to USD 393.22 Billion by 2033, growing at a CAGR of 7.4% during the forecast period (2026-2033).

The global fecal occult testing market is crucial for detecting hidden blood in stool samples, which is indicative of various medical conditions including colon cancer, polyps, and inflammatory bowel diseases. The demand for this screening method is increasing due to the rising incidence of colorectal cancer, government initiatives promoting awareness, and advancements in medical technology and testing techniques. Despite barriers such as low public awareness and cost concerns, opportunities abound through the rise of direct-to-consumer lab tests and the availability of testing devices online. The market encompasses different product types, such as guaiac FOB, immuno-FOB tests, and is utilized in various clinical settings including hospitals and diagnostic laboratories, with a broad geographical presence across key global regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fecal Occult Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fecal Occult Testing Market Segments Analysis

Global Fecal Occult Testing Market is segmented by Test Type, Application, End-use and region. Based on Test Type, the market is segmented into Guaiac FOB stool test, Immuno-FOB agglutination test, Lateral flow immuno-FOB test and Immuno-FOB ELISA test. Based on Application, the market is segmented into Colorectal Cancer, Gastrointestinal Bleeding, Anemia and Others. Based on End-use, the market is segmented into Hospitals, Diagnostic centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fecal Occult Testing Market

The Global Fecal Occult Testing market is significantly influenced by heightened public awareness surrounding colorectal cancer and the importance of regular screening measures. Efforts such as healthcare initiatives and awareness campaigns encourage both individuals and healthcare professionals to prioritize screening. Additionally, government-sponsored programs and established guidelines promoting routine fecal occult blood testing for specific age demographics contribute to the growing demand for these diagnostic tests. This combination of education and structured recommendations is fostering a more proactive approach to colorectal cancer prevention and detection, thereby boosting the market for fecal occult testing as an essential health measure.

Restraints in the Global Fecal Occult Testing Market

The global fecal occult testing market faces significant challenges related to the potential for false positive and false negative results, which can undermine diagnostic reliability and create patient concern or overconfidence. False positives may lead to unnecessary additional tests or invasive procedures, while false negatives can result in missed diagnoses, further delaying essential treatment. It is vital to address these limitations regarding the sensitivity and specificity of fecal occult blood tests to ensure continued trust in their diagnostic capabilities. By improving the accuracy of these tests, the market can better serve both healthcare providers and patients, ultimately enhancing outcomes and care quality.

Market Trends of the Global Fecal Occult Testing Market

The Global Fecal Occult Testing market is increasingly leaning towards point-of-care testing, driven by the demand for rapid results and enhanced convenience. This trend emphasizes accessibility in primary care settings, community health clinics, and remote areas with limited laboratory facilities. The development of user-friendly, cost-effective point-of-care fecal occult blood tests presents a significant opportunity to broaden screening and diagnostic services, particularly in resource-constrained environments. As healthcare systems prioritize early detection and preventive measures, the market is poised for growth, fostering innovations that facilitate access and improve patient outcomes across diverse populations.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Fecal Occult Testing Market Size by Test Type & CAGR (2026-2033)

Market Overview
Guaiac FOB stool test
Immuno-FOB agglutination test
Lateral flow immuno-FOB test
Immuno-FOB ELISA test

Global Fecal Occult Testing Market Size by Application & CAGR (2026-2033)

Market Overview
Colorectal Cancer
Gastrointestinal Bleeding
Anemia
Others

Global Fecal Occult Testing Market Size by End-use & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostic centers
Others

Global Fecal Occult Testing Market Size & CAGR (2026-2033)

North America (Test Type, Application, End-use)
- US
- Canada
Europe (Test Type, Application, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Type, Application, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Type, Application, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Test Type, Application, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Quidel Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wondfo (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eiken Chemical Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biohit Oyj (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inova Diagnostics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
US Diagnostics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sekisui Diagnostics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FUJIFILM Wako Pure Chemical Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helena Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Exact Sciences Corp. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments